The North Carolina Senate is moving quickly on legislation that would impose new restrictions on hemp-derived THC products, including a ban on the sale of certain drinks and edibles to those under 21. The Senate Standing Committee on Health Care is scheduled to vote on the proposal Tuesday morning, with lawmakers aiming to pass the …
Category: News
Marijuana Legalization at Center of Pennsylvania Budget Talks as Deadline Nears
With just two weeks left before Pennsylvania’s new fiscal year begins on July 1, the push to legalize marijuana for adult use is emerging as a central issue in ongoing budget negotiations. Governor Josh Shapiro’s $51.5 billion budget plan depends in part on new revenue from legal cannabis sales—part of a broader Democratic effort to …
New York Senate Approves Bill to Extend Marijuana Tax Filing Deadlines, Assembly Companion Advances
The New York Senate has approved a bill that would give marijuana distributors more time to submit their quarterly tax returns, passing the measure 38 to 21 last week. The proposal, Senate Bill 8091 and Assembly Bill 5496, is sponsored by Senator Jeremy Cooney (D) and Assemblymember Donna Lupardo (D). The legislation would amend Section …
Alabama Senator Tim Melson (R) Pens Op-Ed on Why Cannabis Rescheduling is “Urgent”
Alabama State Senator Tim Melson, a Republican and practicing anesthesiologist, is urging federal officials to reschedule marijuana, calling the move “urgent” in a new op-ed published by the Alabama Daily News. Melson, who sponsored Alabama’s medical marijuana law—the 2021 Compassion Act—used the piece to advocate for reclassifying marijuana from Schedule I to Schedule III under …
Study: Single Dose of Psilocybin Reduced Depression and Anxiety in Cancer Patients, With Benefits Lasting Two Years
A single dose of psilocybin paired with psychotherapy significantly reduced symptoms of depression and anxiety in cancer patients, with many maintaining improvements for two years, according to a new study published in the journal Cancer. The phase 2 trial followed 30 cancer patients diagnosed with major depressive disorder who received a 25 mg dose of …
Arkansas Now Has Over 110,000 Registered Medical Cannabis Patients
Arkansas now has over 110,000 registered medical marijuana patients, according to data provided by the state’s Department of Health. The figure reflects steady growth in the program, with nearly 10,000 new patients added since the start of 2025. In total, there is now 110,554 medical cannabis patients in Arkansas. Medical marijuana was legalized in Arkansas …
Study: Majority of CBD Tinctures Sold Online Are Inaccurately Labeled
A new study from Texas A&M University has found that two-thirds of CBD tinctures sold online in the United States are inaccurately labeled. Researchers tested 18 tinctures marketed as either full-spectrum or broad-spectrum CBD and discovered that two-thirds—12 of the 18—had CBD levels that deviated by more than 10% from what was stated on the …
Study: Most Chronic Pain Patients Report Daily Marijuana Use With High Efficacy and Minimal Cognitive Side Effects
A large majority of chronic pain patients certified to use medical marijuana report using it daily and experiencing strong symptom relief, with few side effects, according to a new study published in Cureus. Researchers from Rothman Orthopaedic Institute, Penn State College of Medicine, and Thomas Jefferson University conducted a prospective study of 129 patients certified …
Global Cannabis Cultivation Market Expected to Hit $652 Billion by 2034, Finds Report
The global cannabis cultivation industry is projected to grow from $180.7 billion in 2025 to $651.8 billion by 2034, according to a new report released by Research and Markets. The report anticipates a compound annual growth rate of 15.3%, driven by expanding legalization, increasing demand for premium cannabis, and continued advances in cultivation technology. The …
Study: Low-Dose CBD Produces Antidepressant Effects in Adolescent Rats Without Long-Term Cognitive Impact
According to a new study published in the journal Pharmacological Reports, cannabidiol (CBD) provided antidepressant-like effects in adolescent rats, with no apparent long-term consequences on cognition or emotional behavior. For the study, researchers administered CBD at varying doses (10, 30, and 60 mg/kg) to adolescent male and female rats over the course of seven days. …
Sponsored
